162 related articles for article (PubMed ID: 1949026)
1. The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia.
Jensen CB; Jollow DJ
Toxicol Appl Pharmacol; 1991 Oct; 111(1):1-12. PubMed ID: 1949026
[TBL] [Abstract][Full Text] [Related]
2. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
Bolchoz LJ; Budinsky RA; McMillan DC; Jollow DJ
J Pharmacol Exp Ther; 2001 May; 297(2):509-15. PubMed ID: 11303037
[TBL] [Abstract][Full Text] [Related]
3. Suppression of phenacetin-induced methemoglobinemia by diethyldithiocarbamate and carbon disulfide and its relation to phenacetin metabolism in mice.
Nakayama N; Masuda Y
J Pharmacobiodyn; 1985 Oct; 8(10):868-76. PubMed ID: 3005542
[TBL] [Abstract][Full Text] [Related]
4. Metabolic activation of phenacetin and phenetidine by several forms of cytochrome P-450 purified from liver microsomes of rats and hamsters.
Nohmi T; Mizokami K; Kawano S; Fukuhara M; Ishidate M
Jpn J Cancer Res; 1987 Feb; 78(2):153-61. PubMed ID: 3104258
[TBL] [Abstract][Full Text] [Related]
5. Metabolic activation by human arylacetamide deacetylase, CYP2E1, and CYP1A2 causes phenacetin-induced methemoglobinemia.
Kobayashi Y; Fukami T; Higuchi R; Nakajima M; Yokoi T
Biochem Pharmacol; 2012 Nov; 84(9):1196-206. PubMed ID: 22940574
[TBL] [Abstract][Full Text] [Related]
6. Role of metabolites in propanil-induced hemolytic anemia.
McMillan DC; Bradshaw TP; Hinson JA; Jollow DJ
Toxicol Appl Pharmacol; 1991 Aug; 110(1):70-8. PubMed ID: 1871773
[TBL] [Abstract][Full Text] [Related]
7. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
[TBL] [Abstract][Full Text] [Related]
8. Role of aniline metabolites in aniline-induced hemolytic anemia.
Harrison JH; Jollow DJ
J Pharmacol Exp Ther; 1986 Sep; 238(3):1045-54. PubMed ID: 3746658
[TBL] [Abstract][Full Text] [Related]
9. Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.
Grossman SJ; Jollow DJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):118-25. PubMed ID: 3335994
[TBL] [Abstract][Full Text] [Related]
10. Reaction of mutagenic phenacetin metabolites with glutathione and DNA. Possible implications for toxicity.
Mulder GJ; Kadlubar FF; Mays JB; Hinson JA
Mol Pharmacol; 1984 Sep; 26(2):342-7. PubMed ID: 6482879
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced hemolysis: biochemical considerations.
Shahidi NT
Birth Defects Orig Artic Ser; 1970 Jun; 6(2):9-15. PubMed ID: 5522339
[No Abstract] [Full Text] [Related]
12. Phenacetin-induced hemolytic anemia.
Millar J; Péloquin R; De Leeuw NK
Can Med Assoc J; 1972 Apr; 106(7):770-5. PubMed ID: 5016923
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of phenacetin and N-hydroxyphenacetin in isolated rat hepatocytes.
McLean S
Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):173-80. PubMed ID: 732893
[TBL] [Abstract][Full Text] [Related]
14. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
Grossman S; Budinsky R; Jollow D
J Pharmacol Exp Ther; 1995 May; 273(2):870-7. PubMed ID: 7752092
[TBL] [Abstract][Full Text] [Related]
15. Mutagenicity of the phenacetin metabolites: N-hydroxy-p-phenetidine and nitrosophenetol in S. typhimurium TA100 and derivatives deficient in nitroreductase or O-acetylase: probes for testing intrabacterial metabolic activation.
McCoy EC; Rosenkranz HS; Bartsch H
Mutat Res; 1986 Apr; 173(4):245-50. PubMed ID: 3513003
[TBL] [Abstract][Full Text] [Related]
16. Development of tolerance to 2-butoxyethanol-induced hemolytic anemia and studies to elucidate the underlying mechanisms.
Ghanayem BI; Sanchez IM; Matthews HB
Toxicol Appl Pharmacol; 1992 Feb; 112(2):198-206. PubMed ID: 1539158
[TBL] [Abstract][Full Text] [Related]
17. Formation of 4-ethoxy-4'-nitrosodiphenylamine in the reaction of the phenacetin metabolite 4-nitrosophenetol with glutathione.
Klehr H; Eyer P; Schäfer W
Biol Chem Hoppe Seyler; 1987 Aug; 368(8):895-902. PubMed ID: 3663328
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and cellular basis of 2-butoxyethanol-induced hemolytic anemia in rats and assessment of human risk in vitro.
Ghanayem BI
Biochem Pharmacol; 1989 May; 38(10):1679-84. PubMed ID: 2730682
[TBL] [Abstract][Full Text] [Related]
19. Role of oxidant stress in lawsone-induced hemolytic anemia.
McMillan DC; Sarvate SD; Oatis JE; Jollow DJ
Toxicol Sci; 2004 Dec; 82(2):647-55. PubMed ID: 15456924
[TBL] [Abstract][Full Text] [Related]
20. A toxicogenomic approach revealed hepatic gene expression changes mechanistically linked to drug-induced hemolytic anemia.
Rokushima M; Omi K; Araki A; Kyokawa Y; Furukawa N; Itoh F; Imura K; Takeuchi K; Okada M; Kato I; Ishizaki J
Toxicol Sci; 2007 Feb; 95(2):474-84. PubMed ID: 17082564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
